Elevra Lithium Quarterly Activities Report
BRISBANE, Australia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Elevra Lithium (“Company”) (ASX: ELV; NASDAQ: ELVR) delivered record ore mined and processed at North American Lithium, second highest production on record, increased sales volumes, higher realised pricing and reduced unit cost of sales.
Covered in this story
Analyst targets on Elevance Health
- Guggenheim: $421 → $460 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ELV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Elevance Health →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.